Cambridge Nutritional Sciences (LON:CNSL – Get Free Report) announced its earnings results on Tuesday. The company reported GBX (0.30) earnings per share (EPS) for the quarter, Digital Look Earnings reports. The firm had revenue of GBX 236 million during the quarter. Cambridge Nutritional Sciences had a negative net margin of 83.53% and a negative return on equity of 69.62%.
Cambridge Nutritional Sciences Trading Down 3.2%
CNSL stock traded down GBX 0.05 on Tuesday, hitting GBX 1.50. The company’s stock had a trading volume of 1,287,443 shares, compared to its average volume of 289,956. Cambridge Nutritional Sciences has a 1 year low of GBX 1.25 and a 1 year high of GBX 2.50. The stock has a market cap of £3.57 million, a price-to-earnings ratio of -0.62 and a beta of 1.91. The firm has a 50 day moving average of GBX 1.56 and a two-hundred day moving average of GBX 1.80.
Cambridge Nutritional Sciences Company Profile
Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.
Featured Stories
- Five stocks we like better than Cambridge Nutritional Sciences
- Axon vs. Motorola: Which Public Safety Stock Has More Upside After Q3 Earnings?
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
Receive News & Ratings for Cambridge Nutritional Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Nutritional Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
